Evidence map›Paper›PMID 41079069›Full record

ArticleFrontiers in oncology2025

Building and sustaining infection prevention and control teams at two pediatric cancer units in Ecuador and Guatemala through a collaboration partnership.

Joanna J Acebo, Mario A Melgar, Maysam R Homsi, Miriam L Gonzalez, Alicia C Cojulun, Federico Antillon-Klussmann, Jose M Eguiguren, Elaine I Tuomanen, Miguela A Caniza

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Joanna J Acebo *Pediatric Oncology Service, Hospital SOLCA Quito, Quito, Ecuador.
Mario A Melgar *Unidad Nacional de Oncología Pediátrica, and School of Medicine, Francisco Marroquin University, Guatemala, Guatemala.
Maysam R HomsiDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
Miriam L GonzalezDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
Alicia C CojulunUnidad Nacional de Oncología Pediátrica, and School of Medicine, Francisco Marroquin University, Guatemala, Guatemala.
Federico Antillon-KlussmannUnidad Nacional de Oncología Pediátrica, and School of Medicine, Francisco Marroquin University, Guatemala, Guatemala.
Jose M EguigurenHospital Metropolitano de Quito, Quito, Ecuador.
Elaine I TuomanenDepartment of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN, United States.
Miguela A CanizaDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hospital infection prevention and control (IPC) programs are often insufficient to meet the needs of pediatric oncology units (POUs) in low-resource settings. Accordingly, we established partnerships to build and sustain dedicated IPC teams for two POUs in Ecuador and Guatemala. Methods: Each partnership comprised four phases: (1) planning and preparation; (2) developing the IPC team; (3) sustaining the IPC team; and (4) integrating the IPC team into the institution. The impact of the IPC teams was assessed by monitoring healthcare-associated infections (HAIs) and compliance with IPC practices. Results: At Hospital SOLCA-Quito, Ecuador, local champions were identified and trained. These in turn built local IPC teams that led healthcare improvement by using surveillance for outcome measures, monitoring practices for processes measures, and staff training. As the collaboration progressed, infection rates decreased steadily. At SOLCA-Quito, there were 9 HAIs/1000 patient days at baseline in 2010, whereas at the end of 2019, there were 2.6 HAIs/1000 patient days. A similar program was developed at the UNOP hospital in Guatemala, where the HAI rate decreased from 9.9/1000 patient days in 2011 to 5.37/1000 patient days in 2019 and the CLABSI rate decreased from 32.75/1000 catheter days in 2008 to 3.11/1000 catheter days in 2019. Towards the end of the collaborations, the IPC teams were integrated into the institutional structures. The Ecuadorean IPC team was integrated as a link team between the pediatric oncology service and the hospital IPC program. The Guatemalan team became the institutional IPC program staff. Conclusions: Our collaborations decreased HAIs in two POUs. The model proved sustainable and became part of the institutional structures, and it has been replicated in POUs elsewhere.

Indexed as

cancerEcuadorGuatemalainfection prevention and controllink teamslow- and middle-income countriespediatric

Identifiers

PMID41079069
PMCPMC12507594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.